Koopman, Gerrit
Amacker, Mario
Stegmann, Toon
Verschoor, Ernst J.
Verstrepen, Babs E.
Bhoelan, Farien
Bemelman, Denzel
Böszörményi, Kinga P.
Fagrouch, Zahra
Kiemenyi-Kayere, Gwendoline
Mortier, Daniella
Verel, Dagmar E.
Niphuis, Henk
Acar, Roja Fidel
Kondova, Ivanela
Kap, Yolanda S.
Bogers, Willy M. J. M.
Mooij, Petra
Fleury, Sylvain
Funding for this research was provided by:
European Commission (TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08, TRANSVAC2 2002-08-AVVAX-COVID-19, TRANSVAC2_TNA2002-08)
Biomedical Primate Research Centre
Mymetics
Article History
Received: 13 January 2023
Accepted: 17 March 2023
First Online: 28 March 2023
Competing interests
: S.F. and T.S. own equity in the mother company Mymetics Corporation that holds Mymetics BV and Mymetics SA. The remaining authors G.K., M.A., E.J.V., B.E.V., F.B., D.B., K.P.B., Z.F., G.K.-K., D.M., D.E.V., H.N., R.F.A., I.K., Y.S.K., W.M. J. M.B., and P.M. declare that the research was conducted in the absence of any financial and non-financial (also S.F. and T.S.) relationships that could be construed as a potential conflict of interest.